Here is the latest stock price and chart of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
FREE Event: How to Profit from the Massive Upcoming Revival in Smallcaps
Live BSE Quotes | Jan 22, 2021 (Close) | ||
---|---|---|---|
Price (Rs)3,723.05 | Open (Rs) 3,785.00 | High (Rs) 3,800.00 | Low (Rs) 3,710.00 |
% Change-2.69 | Volume 13,102 | Value (Rs) 49,075,679 | 52-Week H/L 4,970.00 / 1,888.00 |
Live NSE Quotes | Jan 22, 2021 (Close) | ||
---|---|---|---|
Price (Rs)3,724.70 | Open (Rs) 3,790.00 | High (Rs) 3,800.00 | Low (Rs) 3,710.00 |
% Change-2.24 | Volume 80,950 | Value (Rs) 301,514,465 | 52-Week H/L 4,970.00 / 1,885.00 |
Change | |||||
---|---|---|---|---|---|
1 Day -2.69% | 1 Month -10.89% | 3 Months -12.01% | 1 Year 47.09% | 5 Years (CAGR)* 25.39% | 10 Years (CAGR)* 11.67% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 27.73 | P/E Ratio (x) 134.25 | Market Cap (Rs m) 93,076.25 | P/BV (x) 37.69 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
ASTRAZENECA PHARMA last traded price was down 2.7% to Rs 3,723.1 on the BSE. On the NSE, ASTRAZENECA PHARMA last traded price was down 2.2% to Rs 3,724.7. The total volume of shares traded was 0.1 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.2%. And the benchmark S&P BSE SENSEX was at 48,878.5 (down 1.5%).
Over the last 30 days, the ASTRAZENECA PHARMA share price is down 12.7%. And over the last one year, ASTRAZENECA PHARMA share price is up 46.7%.
What else is happening in the markets today? Dig in...
The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.
For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.
For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.
Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More